[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Knight Therapeutics Inc (GUD.TO)

Knight Therapeutics Inc (GUD.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Knight Therapeutics Inc 100 Alexis Nihon Boulevard Suite 600 Saint-Laurent QC H4M 2P2 CAN

https://www.gud-knight.com P: 514-484-4483 F: 514-481-4116

Sector:

Medical

Description:

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and commercializing pharmaceuticalproducts. and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Latin America and select international markets. The company finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights. Geographically, the company generates revenue from Brazil, Canada, Colombia, Argentina, Mexico, Rest of LATAM, and Others, with the majority revenue generated from the Brazil region.

Key Statistics

Overview:

Market Capitalization, $K 966,085
Shares Outstanding, K 98,179
% of Institutional Shareholders 22.73%

Financials:

Annual Sales, $ 450,088 K
Annual Net Income, $ -5,374 K
Last Quarter Sales, $ 148,439 K
Last Quarter Net Income, $ 13,169 K

Growth:

1-Year Return 61.05%
3-Year Return 106.29%
5-Year Return 90.33%
5-Year Revenue Growth 17.67%

Per-Share Information:

Most Recent Earnings 0.13 on 05/07/26
Next Earnings Date 08/06/26 [--]
Earnings Per Share ttm 0.06
EPS Growth vs. Prev Qtr 44.44%
EPS Growth vs. Prev Year -50.42%
Dividend Payout Ratio 0.00%

GUD.TO Ratios

Ratio
Price/Earnings ttm 164.00
Price/Earnings forward 57.80
Price/Earnings to Growth N/A
Return-on-Equity % 0.71%
Return-on-Assets % 0.54%
Profit Margin % -1.19%
Debt/Equity 0.08
Price/Sales 1.91
Price/Book 1.23
Book Value/Share 8.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.